Mathias Dahlmann
Overview
Explore the profile of Mathias Dahlmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Behrens D, Pfohl U, Conrad T, Becker M, Brzezicha B, Buttner B, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136299
Patient-derived xenograft (PDX) tumor models are essential for identifying new biomarkers, signaling pathways and novel targets, to better define key factors of therapy response and resistance mechanisms. Therefore, this study...
2.
Sagini M, Zepp M, Eyol E, Ali D, Gromova S, Dahlmann M, et al.
Peptides
. 2023 Nov;
175:171111.
PMID: 38036098
Endogenous peptide inhibitor for CXCR4 (EPI-X4) is a CXCR4 antagonist with potential for cancer therapy. It is a processed fragment of serum albumin from the hemofiltrate of dialysis patients. This...
3.
Alcaniz J, Winkler L, Dahlmann M, Becker M, Orthmann A, Haybaeck J, et al.
Front Oncol
. 2023 Apr;
13:1129627.
PMID: 37114125
Glioblastoma (GBM) heterogeneity, aggressiveness and infiltrative growth drastically limit success of current standard of care drugs and efficacy of various new therapeutic approaches. There is a need for new therapies...
4.
Kortum B, Radhakrishnan H, Zincke F, Sachse C, Burock S, Keilholz U, et al.
Oncogene
. 2022 Aug;
41(39):4446-4458.
PMID: 36008464
Colorectal cancer (CRC) is the second-most common malignant disease worldwide, and metastasis is the main culprit of CRC-related death. Metachronous metastases remain to be an unpredictable, unpreventable, and fatal complication,...
5.
Basti A, Malhan D, Dumbani M, Dahlmann M, Stein U, Relogio A
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884519
The circadian clock coordinates the timing of several cellular processes including transcription, the cell cycle, and metabolism. Disruptions in the clock machinery trigger the abnormal regulation of cancer hallmarks, impair...
6.
Gurgen D, Becker M, Dahlmann M, Flechsig S, Schaeffeler E, Buttner F, et al.
Front Oncol
. 2022 Jul;
12:889789.
PMID: 35800063
Renal cell carcinoma (RCC) is a kidney cancer with an onset mainly during the sixth or seventh decade of the patient's life. Patients with advanced, metastasized RCC have a poor...
7.
MACC1-Induced Collective Migration Is Promoted by Proliferation Rather Than Single Cell Biomechanics
Hohmann T, Hohmann U, Dahlmann M, Kobelt D, Stein U, Dehghani F
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740524
Metastasis-associated in colon cancer 1 (MACC1) is a marker for metastasis, tumor cell migration, and increased proliferation in colorectal cancer (CRC). Tumors with high MACC1 expression show a worse prognosis...
8.
Schmid F, Dahlmann M, Rohrich H, Kobelt D, Hoffmann J, Burock S, et al.
Br J Cancer
. 2022 May;
127(4):675-685.
PMID: 35597866
Background: The metastasis inducing gene MACC1 is a prognostic and predictive biomarker for metastasis in several cancers. Its mechanism of inducing metastasis includes the transcriptional control of other cancer-related target...
9.
Dahlmann M, Monks A, Harris E, Kobelt D, Osterland M, Khaireddine F, et al.
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008201
Metastasis is directly linked to colorectal cancer (CRC) patient survival. Wnt signaling through β-catenin plays a key role. Metastasis-inducing S100A4 is a Wnt/β-catenin target gene and a prognostic biomarker for...
10.
Dahlmann M, Gambara G, Brzezicha B, Popp O, Pachmayr E, Wedeken L, et al.
Mol Cancer
. 2021 Oct;
20(1):129.
PMID: 34670579
No abstract available.